View clinical trials related to Arterial Disease of Legs.
Filter by:This is a randomised, placebo-controlled, single blind, multicentre trial. The main goal of this clinical trial is to determine the effectiveness (primary patency) and safety of the sirolimus DCB versus standard PTA for the treatment of below the knee arterial disease. Participants will be randomized to receive either: 1. MagicTouch PTA sirolimus coated balloon catheter (DCB) in addition to standard balloon angioplasty or 2. Placebo balloon angioplasty in addition to standard balloon angioplasty (PTA).